NCT04298346View on ClinicalTrials.gov

Neurological Fate, Prematurity and Genetic Susceptibility Factors

CompletedOBSERVATIONAL
Enrollment

27

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Polymorphism, Restriction Fragment LengthPrematureInfertility of Cervical Origin
Interventions
OTHER

no intervention

no intervention

Trial Locations (1)

44000

CHU Nantes, Nantes

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT04298346 - Neurological Fate, Prematurity and Genetic Susceptibility Factors | Biotech Hunter | Biotech Hunter